首页> 美国卫生研究院文献>Journal of Clinical and Experimental Hepatology >Joint Guidance from SGEI ISG and INASL for Gastroenterologists and Gastrointestinal Endoscopists on the Prevention Care and Management of Patients With COVID-19
【2h】

Joint Guidance from SGEI ISG and INASL for Gastroenterologists and Gastrointestinal Endoscopists on the Prevention Care and Management of Patients With COVID-19

机译:SGEIISG和INASL为胃肠病学家和胃肠内镜医师提供的预防护理和管理COVID-19患者的联合指南

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Coronavirus disease 2019 (COVID-19), which started in December 2019 in China, has resulted in a pandemic leading to significant morbidity and mortality across the globe. Although it mainly causes respiratory symptoms, respiratory failure and death due to multiorgan failure, there is evolving evidence to suggest gastrointestinal (GI) and liver involvement by this virus. Owing to this, health-care professionals taking care of GI and liver diseases are also at an increased risk of getting exposed. Hence, there is a need for protocols to be prepared to guide the handling of COVID-19 patients by the GI and liver specialists, as well as to manage the pre-existing GI and liver diseases during the ongoing pandemic. We present here the guidelines prepared jointly by the three Indian professional bodies in the field of GI diseases, namely the Society of Gastrointestinal Endoscopy of India, Indian Society of Gastroenterology, and Indian National Association for the Study of the Liver.
机译:于2019年12月在中国开始的2019年冠状病毒疾病(COVID-19)已导致大流行,导致全球范围内大量发病和死亡。尽管它主要引起呼吸道症状,呼吸衰竭以及由于多器官衰竭而导致的死亡,但是有不断发展的证据表明该病毒会引起胃肠道(GI)和肝脏受累。因此,照顾胃肠道和肝脏疾病的卫生保健专业人员也面临着增加暴露的风险。因此,需要准备规程以指导胃肠道和肝病专家对COVID-19患者的处理,以及在持续的大流行期间管理先前存在的胃肠道和肝病。我们在这里介绍由印度胃肠道内窥镜学会,印度胃肠病学会和印度国家肝脏研究协会这三个印度胃肠道疾病专业机构共同制定的指南。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号